we conclude that 1 ) anti-ea ( r ) antibodies develop with considerable frequency following im and are not a marker , as previously proposed , of unusually severe disease , and 2 ) corticosteroid therapy may retard the formation of anti-ebna antibodies but it does not otherwise influence the humoral immune response to ebv .
C0003320
ebna
C0020967
humoral immune response